Pierre Lutgen currently he is working as an research scientist in the department of clinical trails

Clinical trails

Jin-Feng Hu, born in Hubei Province (1967), studied organic chemistry at Lanzhou University, where he obtained his B.Sc. (1990) and Ph.D. (1996) degrees in Natural Organic Chemistry under the supervision of Professor Zhong-Jian Jia. He was a postdoctoral fellow (1996-1998) in the Department of Natural Products Chemistry, Institute of Materia Medica (Chinese Academy of Medical Sciences and Peking Union Medical College), with Professor Xiao-Zhang Feng. He joined the Hans-Knoell-Institute for Natural Products Research as a German BMBF & DLR fellow (1998-2000) with Professors Susanne Grabley and Ralf Thiericke. He moved to the United States as a postdoctoral associate at the Department of Pharmacognosy, the University of Mississippi, with Professor Mark T. Hamann (2000–2001), and at the Genomics Institute of the Novartis Research Foundation and The Scripps Research Institute, with Professor Peter G. Schultz (2001-2002). He left his position as a Principal Scientist in Natural Products Chemistry from Sequoia Sciences, Inc. (U.S.A.), where he worked from 2002 to 2006, and since has been a Full Professor of Natural Products for Chemical Genetic Research at the Key Laboratory of Brain Functional Genomics (Ministry of Education), East China Normal University. Most recently (2011), Dr. Hu joined the Faculty of the Pharmacy School at Fudan University and has been appointed as Chair of the Department of Natural Products Chemistry. His group is actively involved in the isolation, structure elucidation and synthetic optimization of bioactive natural products and chemical biology studies. He has authored over 80 scientific publications.

Natural Products Chemistry

Alberto Alcibiades Salazar Granara is a Physician and has completed his PhD in Medicine and MSc in Pharmacology in the USMP, also, has a postdoctoral study in the Universidade de Sao Paulo School of Medicine, and the Universidade Federal de Rio Grande do Sul and Hospital Clinicas de Porto Alegre. He is the director of Center of Traditional Medicine and Pharmacology (USMP). He has published more than 20 papers in reputed journals, his interests are the studied the Peruvian medicinal plants, also, in discover off-label effect from the common drugs, likewise, the pharmacogenetic and pharmacokinetic highlight markers in Peruvian population.

Pharmacogenetic and Pharmacokinetic

Syed Akheel Ahmed is a Dean of Faculty of Science and Technology at University of Mysore,Karnataka India.

Biochemistry and Biotechnology: Clinical Pathology, Bioplatform Molecules from Nutraceutical Industrial Spent, Environmental Science: E-Waste Management, Waste Minimization for Reducing Carbon Footprint  Polymer Science and Technology: Conducting Polymers, Green Composites, Nanocomposites, Chemistry: Green Spectrophotometric Methods for Theraupeutic Molecules and Environmental Toxicants, Redox Studies

Rahman graduated as a pharmacist from the Faculty of Pharmacy of University of Dhaka, Bangladesh in 1996. He worked for 3 years as a research and development pharmacist at SK&F Pharmaceutical before moving to academia in April 2001 and joined the Pharmacy department of University of Asia Pacific as a Lecturer. In October 2003, he was appointed as a Lecturer in pharmaceutical chemistry at Dhaka University and was promoted to Assistant Professor in June 2005. He was awarded a Commonwealth Scholarship in September 2005 to carry out doctoral studies in the United Kingdom. He completed his PhD research at the London School of Pharmacy (now UCL School of Pharmacy) under the supervision of Professor David Thurston (2009). He joined the CRUK Protein-Protein Interaction Research Group as a CRUK Research Fellow in July 2009. He was appointed as a Lecturer in Medicinal Chemistry at King’s College in May 2012.

Medicinal Chemistry

I completed my undergraduate studies in Pharmacy at Curtin University, Australia. I then went on to pursue my Masters(Res) in Chemoinformatics at the University of Sheffield where I was supervised by Prof. Val Gillet. I am currently under the supervision of Dr Andreas Bender where we are working on the computational analysis of diverse phenotypic effect databases in particular traditional medicine and natural products in the hopes of discovering the underlying target(s) modulated and the pathway(s) involved. I am also currently collaborating with the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) where we are utilising in silico approaches to analyse the mode-of-action and safety assessment of novel psychoactive compounds emerging in the EU and beyond.

I have been working on the computational analysis of diverse phenotypic effect databases in particular traditional medicine and natural products in the hopes of discovering the underlying target(s) modulated and the pathway(s) involved. I am also currently collaborating with the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) where we are utilising in silico approaches to analyse the mode-of-action and safety assessment of novel psychoactive compounds emerging in the EU and beyond. Currently, I am incorporating Cheminformatics and Bioinformatics approaches to predict protein targets for novel compounds as well as compounds for novel protein targets.

Gam Lay Harn is currently serves as a professor in School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia. She obtained her Ph.D in the field of Pharmaceutical Chemistry in the same university in year 2001 and was promoted to a full professor in year 2011. Her research study focuses on proteomics of organisms including human diseases, microorganisms and plants. She has published more than 50 papers in reputed journals and edited 5 books of cancer education to patients. She was assigned to a few administrative positions include program chairperson to Pharmaceutical Chemistry department, deputy director and technical director to Doping Control Centre Malaysia.

My research field is in proteomic study, where throughout my years of service in USM, I had identified useful urinary biomarker for diagnosis of kidney stone disease, protein biomarkers for differentiation of the source of gelatin either as halal or non-halal. We had obtained patents for both of these inventions. My other research interests are on cancer research and plant proteomics. In cancer research, we determined the changes of protein profilling in cancerous tissues of different stages, grades and race of the patient. While in plant proteomics, we have identified a few proteins with existing commercial values and we had also identified proteins with anti-cancer properties. Currently, we are embarking on proteomics, metabolomics and lipidomics studies of diabetic mice.

Eva Kassi is workinh as an Associate Professor at University of Athens Greece

Αnalysis of estrogen receptor (alpha and beta)in autoimmune diseases (molecular and functional studies), breast cancer and osteoporosis In vitro evaluation of SERM-like activity of various plant extracts and synthetic compounds similar to phytoestrogens – Focus on their effect in osteoblastic differentiation, Insulin secretion and action (in vivo study) –Interaction with adipocytokines

Paul Long is a Professor at King's College London

Pharmacognosy

Xu is a professor in Beijing Normal University-Hong Kong Baptist University United International College (UIC), Associate Director of UIC Key Lab -Laboratory for Health Promotion Mechanism of Medicinal Food and Folk Remedy, author of over 90 peer-reviewed papers. Dr. Xu received Ph.D in Chungnam National University, South Korea. He conducted postdoctoral research work in North Dakota State University, Purdue University, and Gerald P. Murphy Cancer Foundation during 2005-2009. Dr. Xu is serving as Associate Editor-in-Chief of Food Science and Human Wellness, an Editorial Board member of several international journals.

The overall goal of his research is to understand health promoting effects of phytochemicals. Specific interests include: 1) health benefits (targeted at aging, cancers, obesity, and diabetes) assessment of phytochemicals from traditional Chinese medicines; 2) cellular and molecular mechanisms of bioactive components in disease prevention

Fokialakis Nikolaos is a Assistant Professor at University of Athens Greece,and member Advisary Board of Society for Medicinal Plant and Natural Product Research (GA)

Pharmacognosy and Natural Product Chemistry

Born in Rio de Janeiro, Brazil, in 15 of February of 1972. Fabio Boylan studied Pharmacy at Rio de Janeiro Federal University, in Rio de Janeiro, Brazil. From February 1996 to February 1998, he was Lecturer at the Department of Pharmacognosy, Faculdade de Farmacia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. His Master project "Phylogenetic Trends within Lamiiflorae" was sponsored by CNPq, a Brazilian Governmental Agency for 1.5 years and he got the degree after being evaluated by Dr. Otto Richard Gottlieb. His Ph.D. project "Chemical and Pharmacological Studies on Raphiodon echinus and Marsypianthes chamaedrys" was sponsored by CAPES, another Brazilian Governmental Agency. In several years he was awarded with grants from FAPERJ (Rio de Janeiro Research Supporting Agency) and FINEP in 2003 when he had the opportunity to chair the XII Italian-Latin-American Conference on Ethnomedicine. Also in 2003 he was awarded with a special grant from CNPq due to his scientific collaboration to the Brazilian Science. Fabio stepped up as a senior lecturer at the Faculty of Pharmacy, Federal University of Rio de Janeiro in 1998. In 2006, he started his sabbatical year in the School of Pharmacy and Pharmaceutical Sciences, TCD, where he further served as a research coordinator from 2007-2008 and now is a full time lecturer in Pharmacognosy. He acts an ad hoc reviewer for the following scientific journals: Brazilian Journal of Pharmacognosy, Brazilian Journal of Medicinal Plants, Brazilian Journal of Microbiology, Brazilian Journal of Pharmaceutical Sciences, Phytochemistry, Iheringia Zoologia (Section Botany), Phytotherapy Research, Current Medicinal Chemistry, African Journal of Pharmacology and Pharmaceutical Sciences.

Pharmacognosy